Purdue University

Purdue University College of Pharmacy
Interactive Clinical Modules

Description:

Interactive Clinical Modules

Ten interactive clinical modules have been created for practitioners within institutional and outpatient pharmacy.  Each half hour clinical module (0.5 CPE) will review pharmacotherapy for one of the following disease states:  antibiotic pharmacokinetics/pharmacodynamics, anticoagulation, anxiety/depression, asthma, chronic obstructive pulmonary disease, diabetes, heart failure, hyperlipidemia, hypertension, and pneumonia listed above.  The modules contain updates on new drugs to market, new clinical guideline recommendations, and overall management of each disease state.  The interactive clinical modules are an educational tool to learn new pharmacotherapy information or provide an update within these changing areas of pharmacy practice. They include didactic segments mixed with interactive assessments to apply learned knowledge. 

Needs - To review and update preceptors and students on new drugs and new clinical guidelines.

Audience - Pharmacy preceptors and P4 / APPE rotation students

Overall Learning Objectives -
1.  Discuss the properties and indications for new medications for each specified disease state.
2.  Understand guideline treatment recommendations for specified disease states.
3.  Develop and educate a patient on a therapeutic plan.

Pharmacist Accreditation Statement:  Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/equal opportunity institution.

Titles, UANs, Objectives, Release and Expiration Dates for EACH module are listed below

Faculty Disclosure Statement - All faculty AND staff involved in the planning, review or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Jasmine Gonzalvo, PharmD, Purdue University College of Pharmacy – Discloses that she is on the advisory board for the American Association of Diabetes Educators
Meredith Howard, PharmD, Butler University College of Pharmacy & Health Sciences – Has nothing to disclose
Alex Isaacs, PharmD, Purdue University College of Pharmacy – Has nothing to disclose
Sarah Nisly, PharmD, Butler University College of Pharmacy & Health Sciences – Has nothing to disclose
Alison Walton, PharmD, Butler University College of Pharmacy & Health Sciences – Has nothing to disclose

All additional planning committee members, reviewers, Butler University College of Pharmacy and Purdue University College of Pharmacy staff have no relationships to disclose.

Required for Completion - To receive credit, you must view the module, complete the post-test with at least a 70% passing score, and complete the evaluation/request for credit. ACPE Credits will be uploaded to CPE Monitor within 60 days of completion.

Accreditation questions may be directed to Dawn Sinclair at Purdue University via email sinclaid@purdue.edu. Certificate questions may be directed to Heather Holley at Purdue University via email hholley@purdue.edu.


Anticoagulation and Pharmacotherapy
Universal Activity Number (UAN): 0018-000-16-006-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Understand the place in therapy for the oral anticoagulants.
2.  Review the necessary transitions between anticoagulants
3.  Design and justify a treatment and monitoring plan for patients with an acute thromboembolism.

Anxiety and Depression
Universal Activity Number (UAN): 0018-000-16-007-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Identify important resources for anxiety and depression pharmacotherapy.
2.  Design a first line treatment plan for a patient with generalized anxiety disorder.
3.  Create appropriate pharmacotherapy recommendations for treatment of major depressive disorder (MDD).

Asthma Pharmacotherapy
Universal Activity Number (UAN): 0018-000-16-008-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Identify important online resources for the management of asthma.
2.  Formulate a maintenance treatment plan for a patient with asthma.
3.  Recommend pharmacotherapy for the management of an acute asthma exacerbation.

COPD Pharmacotherapy
Universal Activity Number (UAN): 0018-000-16-009-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Identify important online resources for the management of COPD.
2.  Formulate a maintenance treatment plan for patients with COPD.
3.  Recommend pharmacotherapy for managing an acute COPD exacerbation.

Diabetes
Universal Activity Number (UAN): 0018-000-16-010-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Distinguish type 1 diabetes, type 2 diabetes, and gestational diabetes.
2.  Identify the most appropriate resources related to diabetes.
3.  Name important landmark trials related to diabetes.
4.  Recommend appropriate drug regimen changes based on individual patient characteristics and evidence based guidelines.

Heart Failure Pharmacotherapy
Universal Activity Number (UAN): 0018-000-16-011-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Develop and alter a treatment plan for guideline-directed medical therapy (GDMT) in a patient with heart failure.
2.  Formulate a monitoring plan for the management of a patient with heart failure.
3.  Compare and contrast GDMT for heart failure with a reduced ejection fraction (HFrEF) and heart failure with a preserved ejection fraction (HFpEF).

Hypertension Pharmacotherapy
Universal Activity Number (UAN): 0018-000-16-012-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Identify important medical resources for hypertension management.
2.  Determine blood pressure goals for patients with hypertension.
3.  Formulate a treatment plan for patients with hypertension.

Hyperlipidemia
Universal Activity Number (UAN): 0018-000-16-013-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Identify the most important resources related to hyperlipidemia management.
2.  Compare and contrast the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol and the 2014
NLA Recommendations for Patient-Centered Management of Dyslipidemia.
3.  Recommend appropriate drug regimen changes based on individual patient characteristics and evidence based
guidelines.

Antibiotic Pharmacokinetics & Pharmacodynamics
Universal Activity Number (UAN): 0018-000-16-014-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Review pharmacokinetic equations.
2.  Understand the role of pharmacokinetic monitoring and pharmacodynamics in aminoglycoside dosing.
3.  Understand the role of pharmacokinetic monitoring and pharmacodynamics in vancomycin dosing.

Pneumonia
Universal Activity Number (UAN): 0018-000-16-015-H01-P, 0.5 contact hours (.05 CEU)
Release Date: 01/15/2016   Expiration Date: 01/15/2019
Learning Objectives
-
1.  Identify and discern risk factors for community acquired versus health care associated pneumonia.
2.  Formulate a treatment plan for community acquired pneumonia.
3.  Recommend a pharmacotherapy treatment plan for health care associated pneumonia.
 

Course Section   Add to Cart
Course: 1335 262-00
Term: 16SDL
Section Number: 1
Schedule Number: 17287
Instructor(s): Staff
Units: 0.0 CEUs
Required Fees: Price
Registration Fee$50.00